Pharmaceutical Commerce - February 2023

Disruptive Factors Shape RA Landscape

February 09, 2023



As the range of treatment options for rheumatoid arthritis (RA) continues to grow and biosimilars are poised to enter the arena, the need for expert strategies to improve therapy selection and address the access, affordability, and adherence challenges patients face is coming into sharper focus.